Customized autoantibodies (autoAbs) profiling to predict and monitor immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICI)

被引：0
|
作者：
Genta, Sofia
Keshavarzi, Sareh
Yee, Noelle
Heirali, Alya
Hansen, Aaron Richard
Siu, Lillian L.
Saibil, Samuel
Stayner, Lee-Anne
Yanekina, Maryia
Sauder, Maxwell
Salawu, Abdulazeez
Spiliopoulou, Pavlina
Vornicova, Olga
Vilbert, Maysa Tamara Silveira
Butler, Marcus O.
Bedard, Philippe L.
Razak, Albiruni Ryan Abdul
Coburn, Bryan
Chruscinski, Andrzej
Spreafico, Anna
机构：
[1] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Biostatist, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] Univ Hlth Network, Toronto, ON, Canada
[10] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2528
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
  • [22] Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT)
    Genta, S.
    Yee, N.
    Keshavarzi, S.
    Heirali, A.
    Hansen, A. R.
    Siu, L. L.
    Saibil, S.
    Stayner, L-A.
    Yanekina, M.
    Pimentel Muniz, T.
    Vilbert, M.
    Bedard, P.
    Abdul Razak, A. R.
    Coburn, B.
    Chruscinski, A.
    Spreafico, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S844 - S845
  • [23] Immune-related adverse events of checkpoint inhibitors
    Ramos-Casals, Manuel
    Brahmer, Julie R.
    Callahan, Margaret K.
    Flores-Chavez, Alejandro
    Keegan, Niamh
    Khamashta, Munther A.
    Lambotte, Olivier
    Marlette, Xavier
    Prat, Aleix
    Suarez-Almazor, Maria E.
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [24] Immune-related adverse events of checkpoint inhibitors
    Manuel Ramos-Casals
    Julie R. Brahmer
    Margaret K. Callahan
    Alejandra Flores-Chávez
    Niamh Keegan
    Munther A. Khamashta
    Olivier Lambotte
    Xavier Mariette
    Aleix Prat
    Maria E. Suárez-Almazor
    Nature Reviews Disease Primers, 6
  • [25] Immune-related adverse events of checkpoint inhibitors
    不详
    Nature Reviews Disease Primers, 6 (1) : 39
  • [26] Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.
    Blum, Steven Michael
    Smith, Neal
    Sade-Feldman, Moshe
    Frederick, Dennie T.
    Jenkins, Russell William
    Cohen, Justine Vanessa
    Lawrence, Donald P.
    Mooradian, Meghan
    Freedman, Christine
    Fadden, Riley
    Rubin, Krista M.
    Richey, Sarah
    Flaherty, Keith
    Wargo, Jennifer Ann
    Hacohen, Nir
    Sullivan, Ryan J.
    Boland, Genevieve Marie
    Villani, Alexandra C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
    Barron, Carly C.
    Stefanova, Isabella
    Cha, Yevin
    Elsolh, Karam
    Zereshkian, Arman
    Gaafour, Nessma
    McWhirter, Elaine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [28] Immune-related adverse events (irAE) in GU cancer patients receiving immune checkpoint inhibitors.
    Zang, Peter
    Drakaki, Alexandra
    Faiena, Izak
    Chan, Betty
    Tsao-Wei, Denice
    Groshen, Susan G.
    Quinn, David I.
    Dorff, Tanya B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] Biomarkers to predict immune-related adverse events with checkpoint inhibitors.
    Head, Lia
    Gorden, Nicholas
    Van Gulick, Robert
    Amato, Carol M.
    Frazer-Abel, Ashley
    Robinson, William
    Holers, V. Michael
    Messersmith, Wells A.
    Davis, S. Lindsey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [30] Immune-Related Adverse Events From Immune Checkpoint Inhibitors
    Marrone, K. A.
    Ying, W.
    Naidoo, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 242 - 251
12345